Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Cost Improvement Program Depends On COVID Outlook

01 Aug 2023

• By Jessica Merrill

wallet — Pfizer is reconsidering spending. • Source: Shutterstock

Related Content

How Will Pfizer Plant’s Tornado Damage Impact Congress’s Drug Shortages Debate?

21 Jul 2023

Pfizer Pays $43bn For Seagen With Goal Of Rapidly, Globally Advancing ADCs

13 Mar 2023

GSK And Pfizer RSV Vaccines Get US Recommendation – But Big Decisions On Pricing Yet To Come

22 Jun 2023

From Hallelujah To Headwind: Pfizer's COVID-19 Franchise Hits The Downturn

31 Jan 2023

Related Companies

Pfizer Inc.

Seagen Inc.

BioNTech SE

Additional Topics

Sales & Earnings Coronavirus COVID-19 Business Strategies BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.